AMBUADR

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2025, AMBUADR has already paid €0.0543 in dividends. The last payout was in December 2025.

Financials

In the last quarter, AMBUADR had revenue of €223.19m and net profit of €21.23m

(EUR)	June 2026	YoY
Revenue	223.19m	10.50%
Gross profit	132.69m	11.61%
Net profit	21.23m	28.78%
EBITDA	43.69m	22.53%

Fundamentals

Metric	Value
Market capitalization	€2.77bn
Number of shares	266.51m
52-week high/low	€14.55 - €7.62
Dividend yield	0.62%
Dividends TTM	€0.0543
Beta	1.43
P/E ratio	41.52
PEG ratio	0.98
P/B ratio	3.43
P/S ratio	2.95

Company profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, head immobilizers, CPR breathing barriers, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.